ARK Investment Management’s Fate Therapeutics FATE Stock Holding History

ARK Investment Management’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,214,863	Closed	-$42.5M	–	225
2022 Q4	$42.5M	Sell	4,214,863 -7,440,970	-64%	-$140M	0.37%	42
2022 Q3	$261M	Buy	11,655,833 +182,178	+2%	+$5.26M	1.82%	19
2022 Q2	$265M	Buy	11,473,655 +485,473	+4%	+$13.4M	1.57%	20
2022 Q1	$426M	Buy	10,988,182 +676,015	+7%	+$26.2M	1.78%	17
2021 Q4	$603M	Sell	10,312,167 -590,091	-5%	-$33.4M	1.82%	18
2021 Q3	$646M	Buy	10,902,258 +3,419,156	+46%	+$268M	1.55%	20
2021 Q2	$649M	Buy	7,483,102 +928,556	+14%	+$74.8M	1.21%	26
2021 Q1	$540M	Buy	6,554,546 +3,652,846	+126%	+$350M	1.07%	28
2020 Q4	$264M	Buy	2,901,700 +1,461,730	+102%	+$90.8M	0.7%	41
2020 Q3	$57.6M	Buy	1,439,970 +420,140	+41%	+$14.7M	0.34%	53
2020 Q2	$35M	Buy	1,019,830 +464,748	+84%	+$13.9M	0.38%	45
2020 Q1	$12.3M	Buy	555,082 +123,954	+29%	+$3.13M	0.31%	53
2019 Q4	$8.44M	Buy	431,128 +92,089	+27%	+$1.46M	0.21%	60
2019 Q3	$5.26M	Buy	339,039 +116,975	+53%	+$2.24M	0.11%	71
2019 Q2	$4.51M	Buy	+222,064	New	+$4M	0.11%	75

Other funds holding FATE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return